BIT's 10th World Congress of Vaccine-2017, Singapore
Introduction to WCV-2017 Singapore

Following on the successful organizing of WCV-2017 Beijing, we are pleased to announce the 10th WCV conference will be held during November 15-17, 2017 in Singapore. With the theme of “Accelerating Next Generation Vaccines R & D”, we will once again offer professionals in the field of vaccine a multidisciplinary informative platform.
WCV2017-Singapore contributes to provide a unique platform which will bring together thought leaders from pharmaceutical, biotech companies, consultants, regulatory authorities and academics, to present the latest research results, ideas, developments, applications and business prospects in Vaccine Research and Technologies, Vaccine Drugs, and Production, Vaccine Market Trend & Policy, etc.

Program Layout

Track 1: Latest Research and Technologies in Vaccines Development
Track 2: Vaccines for Emerging and Re-Emerging Diseases
Track 3: Vaccines for Human Diseases
Track 4: Veterinary Vaccines
Track 5: Vaccines Production & Manufacturing
Track 6: Global Vaccines Market Trends and Regulations
Track 7: Hot Topics in Immunology Research
Track 8: Innovative Technology in Immunology
Track 9: Clinical Immunology

Track 10: Posters and Exhibitions
Track 11: Social & Cultural Activities

Past International Renowned Speakers
Dr. Weikang Tao, Vice President and CEO of R&D Center, Jiangsu Henrui Medicine Co., Ltd., China Dr. Madi Madiyalakan, CEO, Quest PharmaTech Inc., Canada Dr. Dan Zhang,Chairman and CEO, Fountain Medical Development Ltd. China
Dr. Michel Klein, CSO, BravoVax Co., Ltd., Canada Dr. Rajesh K. Gupta, Co-Owner & Principal Consultant, Biologics Quality & Regulatory Consultants, LLC, USA Dr. Daming Zhu, Head of Quality Control Unit, NIAID/NIH, USA
Dr. Tom H Jin, Senior Scientist, IDT Biologika, USA Dr. Jung Sun Yum , Executive Director, CHA Vaccine Institute, Korea Dr. Luis H. Martin, CEO, Pan-Provincial Vaccine Enterprise Inc., Canada
Dr. Eiman M A Mokaddas, Professor, Kuwait University, Kuwait Dr. Viliam Pavliak, Head of Vaccine Development, International Vaccine Institute, Korea
Dr. Armando Zuniga, CSO, Virometix AG, Switzerland
Dr. Geert. C. Mudde, CSO and Managing Director, OncoQR ML GmbH, Austria Dr. Yuri M. Vasiliev, Deputry Director, St. Petersburg Research Institute for Vaccines and Sera, Russia photo Ms. Molly (Miao) Zhang, Project Coordinator, Aeras, China
Dr. Tadeusz Stefaniak, Professor, Wroclaw University of Environmental and Life Sciences, Poland Dr. Anna Rzasa, Professor, Wroclaw University of Environmental and Life Sciences, Poland Dr. Artem Metlin, Deputy Director, Federal Centre for Animal Health, Russia
Dr.Andrew A. Potter, CEO, Vaccine and infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), Canada William J. Kelly Dr. William J. Kelly, Professor, Villanova University, USA Mr. Jochen Uhlenküken, Business Development Manager, Hamilton Bonaduz AG, Switzerland
Exhibition and Sponsorship

WCV2017-Singapore provides an ideal platform to showcase your new technologies and products in Singapore. It is developed to maximize your exposure, generate new leads, build brand awareness, and solidify business relations.

WCV2017-Singapore is one of the most effective international marketing platforms in the field of vaccine, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity.

Introduction to Singapore

Singapore has often been described as another Dubai in the making, and, where there is a slight element of truth to the statement, that is not all that Singapore is about. There is a lot more to the city-state than fancy shopping malls and luxury hotels. Singapore also boasts a vibrant history, and several family- and pocket-friendly public spaces, making it worth your while to explore this mini-Dubai.

News Updates
Hosting Organization
Supporting Organizations
Official Travel Agency
BIT's Upcoming Events
©2016-2017 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609-801-801, : 0086-411-84799609-801